Biotech News
Related news
BDSXBiodesix2026-08-04 10:00 EST
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
BDSXBiodesix2026-09-14 20:01 EST
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
XGNExagen2026-10-29 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conferences
LUCDLucid Diagnostics2026-08-04 12:30 EST
Lucid Diagnostics to Participate in Upcoming Investor Conferences
XGNExagen2026-07-28 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conference
LUCDLucid Diagnostics2026-11-04 13:55 EST
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
INBSIntelligent Bio Solutions2026-06-04 12:30 EST
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
BRLIBio-Reference Laboratories2026-09-08 17:55 EST
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
BIAFbioAffinity Technologies, Inc.2026-09-03 20:30 EST
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
INBSIntelligent Bio Solutions2026-09-01 12:30 EST
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
Biodesix
Lung-Disease Diagnostics Biodesix develops and commercializes diagnostic solutions intended to improve clinical decision-making, with a particular focus on lung disease and oncology. Its tests combine multiple analytical technologies with clinical evidence and laboratory operations. Diagnostic Testing The company provides blood-based and...
Recent company news
BDSXBiodesix2026-11-04 11:00 EST
Biodesix to Participate in Upcoming Investor Conferences
BDSXBiodesix2026-10-22 10:00 EST
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
BDSXBiodesix2026-10-19 20:01 EST
American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification
BDSXBiodesix2026-10-19 10:00 EST
Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
BDSXBiodesix2026-10-13 10:00 EST
Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
Stock data
- Close
- 19.84 USD
- Market cap
- 159.89M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States